acetazolamide

Generic: acetazolamide

Labeler: avkare
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name acetazolamide
Generic Name acetazolamide
Labeler avkare
Dosage Form TABLET
Routes
ORAL
Active Ingredients

acetazolamide 125 mg/1

Manufacturer
AvKARE

Identifiers & Regulatory

Product NDC 42291-089
Product ID 42291-089_4b947afe-c73a-556b-e063-6294a90adeef
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA205530
Listing Expiration 2027-12-31
Marketing Start 2017-05-18

Pharmacologic Class

Established (EPC)
carbonic anhydrase inhibitor [epc]
Mechanism of Action
carbonic anhydrase inhibitors [moa]
Chemical Structure
sulfonamides [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 42291089
Hyphenated Format 42291-089

Supplemental Identifiers

RxCUI
197303 197304
UPC
0342291090019
UNII
O3FX965V0I
NUI
N0000175517 N0000000235 M0020790

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name acetazolamide (source: ndc)
Generic Name acetazolamide (source: ndc)
Application Number ANDA205530 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 125 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (42291-089-01)
source: ndc

Packages (1)

42291-089-01 100 TABLET in 1 BOTTLE (42291-089-01)

Ingredients (1)

acetazolamide (125 mg/1)

Linked Drug Pages (1)

acetazolamide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4b947afe-c73a-556b-e063-6294a90adeef", "openfda": {"nui": ["N0000175517", "N0000000235", "M0020790"], "upc": ["0342291090019"], "unii": ["O3FX965V0I"], "rxcui": ["197303", "197304"], "spl_set_id": ["d6fba129-ac6e-4d04-bd09-8470be4e7ecc"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_epc": ["Carbonic Anhydrase Inhibitor [EPC]"], "pharm_class_moa": ["Carbonic Anhydrase Inhibitors [MoA]"], "manufacturer_name": ["AvKARE"]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (42291-089-01)", "package_ndc": "42291-089-01", "marketing_start_date": "20170518"}], "brand_name": "acetazolamide", "product_id": "42291-089_4b947afe-c73a-556b-e063-6294a90adeef", "dosage_form": "TABLET", "pharm_class": ["Carbonic Anhydrase Inhibitor [EPC]", "Carbonic Anhydrase Inhibitors [MoA]", "Sulfonamides [CS]"], "product_ndc": "42291-089", "generic_name": "acetazolamide", "labeler_name": "AvKARE", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "acetazolamide", "active_ingredients": [{"name": "ACETAZOLAMIDE", "strength": "125 mg/1"}], "application_number": "ANDA205530", "marketing_category": "ANDA", "marketing_start_date": "20170518", "listing_expiration_date": "20271231"}